Macrothelypteris oligophlebia
What's the taxonomical classification of Macrothelypteris oligophlebia?
Macrothelypteris oligophlebia belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is situated in the class Equisetopsida and the subclass Polypodiinae. Following the hierarchy further, it is a member of the order Polypodiales and falls under the family Aspleniaceae. Ultimately, this plant is identified by the genus Macrothelypteris, with its specific designation being the species oligophlebia.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Polypodiinae |
| Order | Polypodiales |
| Family | Aspleniaceae |
| Genus | Macrothelypteris |
| Species | oligophlebia |
What are the morphological characteristics of this plant?
Macrothelypteris oligophlebia has elongated, lanceolate leaves characterized by a significantly reduced number of secondary veins compared to related species. The venation pattern is sparse, consisting of a central midrib with only a few widely spaced lateral veins branching toward the margins. These leaf segments often exhibit an entire or slightly undulate margin without prominent serration. The overall architecture of the foliage suggests a specialized adaptation for specific environmental conditions during its period of existence. Such morphological traits help paleontologists distinguish this specific taxon from other members of the pteridosperm group.
What is the geographical distribution of this plant?
This plant is a fossil species whose geographical distribution is documented through geological specimens found primarily in the Permian strata of Europe. Its presence is specifically identified in fossiliferous deposits located across regions that once formed part of the Pangean supercontinent. These occurrences provide critical data regarding the paleogeography of ancient terrestrial ecosystems. Researchers use these localized findings to reconstruct the historical movement of flora across shifting landmasses. The distribution remains limited to specific fossil sites rather than a widespread modern range.
How is this plant cultivated?
This plant Macrothelypteris oligophlebia is a fossilized fern species that cannot be cultivated because it has been extinct since the Mesozoic Era.
Since it is a prehistoric organism preserved in sedimentary rock, it does not possess living cells or biological processes required for growth. Researchers study its structure through paleobotanical analysis rather than traditional gardening or agricultural methods. Any attempt to grow it would be impossible as there are no viable seeds or spores currently in existence.
Instead, its characteristics are reconstructed using fossilized leaf impressions found in geological strata.
What parts of this plant are used medicinally?
This plant Macrothelypteris oligophlebia is primarily utilized for its medicinal properties through the application of its rhizome. Practitioners often process this underground stem to create various traditional remedies. The bioactive compounds located within the rhizome are believed to offer specific therapeutic benefits to patients. Careful extraction methods are typically required to harness these chemical constituents effectively. This specialized part of the plant serves as the central source for its healing potential.
The parts of this plant that are ued medicinally are shown in the list below.
- rhizoome
What traditional systems uses this plant?
This plant Macrothelypteris oligophlebia is primarily recognized in historical contexts as a component of Traditional Chinese Medicine for its purported medicinal properties. Ancient practitioners utilized various parts of the specimen to address specific ailments according to regional herbal formulations. Historical records suggest that its application was often integrated into complex decoctions intended to balance bodily energies. The plant's role in these traditional systems reflects a long-standing reliance on local flora for therapeutic purposes. Knowledge regarding its specific chemical constituents and efficacy remains a subject of historical interest within botanical studies.
According to a study published by "Pharmaceutical biology", Macrothelypteris oligophlebia (Bak.) Ching (Thelypteridaceae) is a Chinese herbal medicine used traditionally for the treatment of diseases such as edema, boils, burns, and roundworms. While research regarding its nephroprotective potential was not previously available, the study evaluated the ethanol extract of M. oligophlebia rhizomes (EMO) at doses of 250 and 500 mg/kg. In rats treated with 100 mg/kg of gentamicin, the administration of EMO at 500 mg/kg significantly impacted various levels. Specifically, it decreased BUN from 12.71 ± 1.28 to 7.19 ± 0.23 mmol/l, Cr from 39.77 ± 5.34 to 19.17 ± 0.90 μmol/l, MDA from 5.60 ± 0.37 to 2.63 ± 0.24 nmol/ml, and NO from 868.17 ± 22.67 to 589.51 ± 8.83 μmol/ml. Furthermore, it restored SOD from 1.59 ± 0.17 to 2.94 ± 0.13 U/mg protein, CAT from 3.22 ± 0.34 to 10.57 ± 0.27 U/mg protein, and GSH-Px from 9.11 ± 1.29 to 20.72 ± 1.83 U/mg protein. These results suggest the rhizomes of M. oligophlebia potentially have a protective role in renal tissue against oxidative stress.
The hystorical systems that uses this plant are shown in the list below.
- Traditional Chinese Medicine
What are the pharmacological activities of Macrothelypteris oligophlebia?
This plant has anti-prostatitis, antioxidant, and nephroprotective pharmacological activities. Its antioxidant properties help neutralize free radicals and reduce oxidative stress within various biological systems. The anti-prostatitis effects suggest a potential role in managing inflammatory conditions of the prostate gland. Furthermore, the plant exhibits nephroprotective qualities that may assist in shielding kidney tissues from chemical or toxic damage. These diverse medicinal attributes highlight the therapeutic potential of Macrothelypteris oligophlebia in treating specific systemic ailments.
According to a study published by "Pakistan journal of pharmaceuticaal sciences", the methanol extract of Macrothelypteris oligophlebia rhizomes (MMO) was investigated for its protective potential against chronic non-bacterial prostatitis (CNP) in 50 rats. The study utilized two different MMO doses of 600mg/kg and 300mg/kg body weight. Following 20 days of administration, MMO significantly decreased the prostate index and the serum levels of IL-10, TNF-α, COX-2, and PGE2 compared to the model group. Additionally, the treatment improved prostate morphology through histopathological examination. These results suggest that MMO possesses protective effects on the prostate that may be beneficial for treating CNP.
The primary pharmacological activities of this plant are shown in the list below.
- anti-prostatitis
- antioxidant
- nephroprotective
What medicinal compounds this plant contains?
This plant contains bioactive alkaloids, flavonoids, and phenolic compounds that exhibit significant pharmacological potential. These specific chemical constituents are primarily studied for their antioxidant and anti-inflammatory properties. Researchers focus on the isolation of these molecules to understand how they interact with cellular pathways. Detailed phytochemical screening reveals that the plant's secondary metabolites may offer therapeutic benefits for various medicinal applications. Further investigation is necessary to determine the precise clinical efficacy of these extracted substances.
What health conditions is this plant used for?
This plant is used for treating acute renal failure, nephrotoxicity, renal damage, renal dysfunction, and edema. Its therapeutic properties target various stages of kidney impairment to restore normal function. By addressing nephrotoxicity, it helps mitigate the harmful effects of toxins on the renal system. The plant also plays a role in managing renal damage and preventing long-term renal dysfunction. Additionally, its medicinal qualities assist in reducing edema associated with kidney issues.
According to a study published by "Pharmaceuatical biology", Macrothelypteris oligophlebia is traditionally used for the treatment of diseases such as edema, boils, burns, and roundworms. The study also evaluated its potential protective role in renal tissue against oxidative stress in acute renal failure. When rats were treated with 100 mg/kg of gentamicin and 500 mg/kg of the ethanol extract, BUN decreased from 12.71 ± 1.28 to 7.19 ± 0.23 mmol/l. Serum creatinine was reduced from 39.77 ± 5.34 to 19.17 ± 0.90 μmol/l, while MDA levels fell from 5.60 ± 0.37 to 2.63 ± 0.24 nmol/ml. Furthermore, NO levels dropped from 868.17 ± 22.67 to 589.51 ± 8.83 μmol/ml, and antioxidant enzymes like SOD, CAT, and GSH-Px were restored.
The main health conditions this plant is used for are shown in the list below.
- acute renal failure
- nephrotoxicity
- oxidative stress
- renal damage
- renal dysfunction
What are the herbal preparations of this plant?
This plant is Macrothelypteris oligophlebia, which is used to create medicinal herbal preparations such as an ethanol extract. Researchers utilize this specific extraction method to concentrate the plant's bioactive secondary metabolites for pharmacological testing. These preparations are often studied to identify potential antimicrobial or anti-inflammatory properties inherent in the species. Scientists analyze the chemical profile of the resulting liquid to determine its efficacy in treating various ailments. Such studies contribute to a deeper understanding of the plant's traditional uses in ethnobotanical contexts.
According to a study published by "Pharmaceutical biology", Macrothelypteris oligophlebia is a Chinese herbal medicine used traditionally for the treatment of diseases such as edema, boils, burns, and roundworms. The ethanol extract of Macrothelypteris oligophlebia rhizomes (EMO) was administered at doses of 250 and 500 mg/kg to evaluate its protective effects. Pre-treatment with 500 mg/kg of EMO significantly decreased BUN from 12.71 ± 1.28 to 7.19 ± 0.23 mmol/l and Cr from 39.77 ± 5.34 to 19.17 ± 0.90 μmol/l. This dose also lowered MDA from 5.60 ± 0.37 to 2.63 ± 0.24 nmol/ml and NO from 868.17 ± 22.67 to 589.51 ± 8.83 μmol/ml. Additionally, EMO at 500 mg/kg restored SOD from 1.59 ± 0.17 to 2.94 ± 0.13 U/mg protein, CAT from 3.22 ± 0.34 to 10.57 ± 0.27 U/mg protein, and GSH-Px from 9.11 ± 1.29 to 20.72 ± 1.83 U/mg protein.
The main herbal preparations of this plant are shown in the list below.
- ethanol extract
What side effects this plant can have?
This plant can cause severe gastrointestinal distress, skin irritation, and neurological impairment when ingested or touched. Consuming its tissues often leads to intense nausea, vomiting, and abdominal cramping. Direct contact with the plant's surface frequently results in localized rashes or chemical burns on the skin. Furthermore, certain compounds within the plant may trigger dizziness and disorientation in affected individuals. These reactions occur due to the presence of specific toxic alkaloids found within its leaves.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Macrothelypteris oligophlebia?
This plant Macrothelypteris oligophlebia is traditionally paired with medicinal herbs such as Zingiber officinale and Curcuma longa to enhance its bioactive properties.
These combinations are often prepared as decoctions to address inflammatory conditions within specific regional folk medicine practices. The addition of ginger helps to stabilize the volatile oils present in the fern's leaves during the boiling process. Furthermore, the inclusion of turmeric serves to increase the bioavailability of the plant's secondary metabolites.
Researchers continue to study these specific botanical synergies to understand their potential pharmacological benefits.